Improving HPV vaccination rates in rural areas
Official title: PREVENT - Practice-based Approaches to Promote HPV Vaccination
Funded at University of Utah · NIH-11077789 · Data updated 2026-11-12
This study is all about helping teenagers in rural areas get the HPV vaccine by finding out what stops them from getting it and coming up with better ways to talk to them and their parents about why it's important.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project start | May 15, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $630,380 |
| NIH project number | 5R01CA279973-03 |
| Project ID | NIH-11077789 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adolescents aged 0-11 years living in rural areas who are eligible for the HPV vaccination.
✕Less likely to help
Patients who live in urban areas or those who are already up-to-date with their HPV vaccinations may not benefit from this research.
What this research studies
This research focuses on increasing the uptake of HPV vaccinations among adolescents, particularly in rural areas where vaccination rates are significantly lower. It aims to identify and address barriers that prevent rural adolescents from receiving the HPV vaccine, such as limited access to healthcare providers and lack of reminders. The study will adapt communication strategies to effectively engage both adolescents and their caregivers about the importance of vaccination. By implementing systematic methods to track eligible patients, the research seeks to enhance outreach efforts and improve vaccination rates.
Why it matters
Potential benefit: If successful, this research could lead to higher HPV vaccination rates, reducing the incidence of HPV-related cancers among adolescents in rural communities.
How similar studies have gone: Previous research has shown that targeted communication and outreach strategies can effectively improve vaccination rates in urban settings, but this approach is novel in rural contexts.
Where this research is happening
-
University of Utah
Salt Lake City, United States Active
Researchers
- Principal investigator: Kepka, Deanna Lee — University of Utah
- Study coordinator: Kepka, Deanna Lee
Related research
Other NIH-funded projects on the same topics.
-
Protective dengue vaccines that steer T and B cell responses
A vaccine study aims to guide the body’s T and B cells to fight all four dengue virus types safely and effectively.
-
Respiratory pathogen–specific T cell signatures after vaccination, infection, and treatment
A research effort to map how immune T cells respond to respiratory infections and vaccines, with potential to guide better vaccines and treatments for conditions like covid-19 and pertussis.
-
Malaria vaccine and infection: how the body’s early and later immune responses relate to protection
Researchers are studying how people’s immune systems respond to the malaria pre-erythrocytic stage, whether after vaccination or infection, to identify which responses are linked to protection.
-
Spatially responsive mass vaccination for urban rabies
A new plan uses data and maps to place vaccination sites where they’re most needed in cities, aiming to boost rabies vaccination for both people and dogs.
-
Spatially responsive mass vaccination for urban rabies
A project tests smarter placement of vaccination sites to increase mass canine rabies vaccination in cities.
-
Vaccine failure after Covid-19 vaccination in older adults
This project follows vaccinated older adults to understand who among them still gets Covid-19 and what factors make those outcomes worse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.